Study Summary
This trial is designed to study the independent and combined effects of four components of mindfulness-based behavioral therapy on eating pathology. The four components are Mindful Awareness, Distress Tolerance, Emotion Modulation, and Values-Based Decision Making. The trial will compare the efficacy of each component when used alone and in combination with standard behavioral treatment for bulimia nervosa and binge eating disorder. The primary aim of the study is to evaluate the independent efficacy of each treatment component on eating pathology. Secondary aims are to test the hypotheses that the efficacy of each component is moderated by related baseline deficits in self-regulation, and to quantify the component interaction
- Bulimia
- Binge-Eating and Purging Type Anorexia Nervosa
- Binge Eating
- Binge Eating Disorder
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
3 Primary · 2 Secondary · Reporting Duration: Changes from each assessment time point throughout treatment (3 assessments over 16 weeks) and 6 month and 1 year post-treatment follow-up assessment
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
16 Treatment Groups
Base BT
1 of 16
Base BT + Distress Tolerance
1 of 16
Base BT + Emotion Regulation
1 of 16
Base BT + Mindful Awareness
1 of 16
Base BT + Values
1 of 16
Base BT + Distress Tolerance and Emotion Modulation
1 of 16
Base BT + Distress Tolerance and Mindful Awareness
1 of 16
Base BT + Distress Tolerance and Values
1 of 16
Base BT + Emotion Modulation and Mindful Awareness
1 of 16
Base BT + Mindful Awareness and Values
1 of 16
Base BT + Emotion Modulation and Values
1 of 16
Base BT + EM, DT, MA
1 of 16
Base BT + DT, ER, and V
1 of 16
Base BT + DT, MA, and V
1 of 16
Base BT + ER, MA, and V
1 of 16
Base BT + ER, MA, V, DT
1 of 16
Active Control
Experimental Treatment
300 Total Participants · 16 Treatment Groups
Primary Treatment: MABT: Mindful Awareness · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 70 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| California | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 100.0% |
Frequently Asked Questions
Do I satisfy the criteria to join this investigation?
"Prospective participants in this clinical trial should have been diagnosed with bulimia nervosa and must be between 18 to 70 years old. A total of 300 individuals will be selected for the trialling period." - Anonymous Online Contributor
Is this medical trial entertaining applicants of advanced age?
"The minimum age for participation in this trial is 18, with a maximum of 70. However, there are 303 trials that cater to minors and 674 specifically designed for seniors." - Anonymous Online Contributor
Is enrollment for this investigation still open?
"Affirmative. Clinicaltrials.gov states that this clinical trial, which was initially posted on June 5th 2020 and most recently updated on September 21st 2021, is actively seeking participants. Approximately 300 candidates are required to be recruited from a single location." - Anonymous Online Contributor
What is the participant enrollment size for this research endeavor?
"Affirmative, the information provided by clinicaltrials.gov confirms that this study is still searching for participants. The trial was initially published on June 5th 2020 and updated recently on September 21st 2021 with a goal of recruiting 300 patients from 1 healthcare site." - Anonymous Online Contributor